vs
Planet Labs PBC（PL）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
Planet Labs PBC的季度营收约是RIGEL PHARMACEUTICALS INC的1.2倍（$81.3M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -72.8%，领先456.9%），Planet Labs PBC同比增速更快（32.6% vs 21.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 17.5%）
Planet Labs PBC（常简称为Planet）是总部位于美国加利福尼亚州旧金山的上市地球影像企业，核心目标是实现全球范围的每日成像，以此监测地表变化、精准识别相关趋势，为多行业的地理数据分析需求提供可靠的数据支持。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
PL vs RIGL — 直观对比
营收规模更大
PL
是对方的1.2倍
$69.8M
营收增速更快
PL
高出11.4%
21.2%
净利率更高
RIGL
高出456.9%
-72.8%
两年增速更快
RIGL
近两年复合增速
17.5%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $81.3M | $69.8M |
| 净利润 | $-59.2M | $268.1M |
| 毛利率 | 57.3% | 91.5% |
| 营业利润率 | -22.6% | 33.2% |
| 净利率 | -72.8% | 384.0% |
| 营收同比 | 32.6% | 21.2% |
| 净利润同比 | -194.7% | 1769.2% |
| 每股收益（稀释后） | $-0.19 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PLRIGL
| Q4 25 | $81.3M | $69.8M | ||
| Q3 25 | $73.4M | $69.5M | ||
| Q2 25 | $66.3M | $101.7M | ||
| Q1 25 | $61.6M | $53.3M | ||
| Q4 24 | $61.3M | $57.6M | ||
| Q3 24 | $61.1M | $55.3M | ||
| Q2 24 | $60.4M | $36.8M | ||
| Q1 24 | $58.9M | $29.5M |
净利润PLRIGL
| Q4 25 | $-59.2M | $268.1M | ||
| Q3 25 | $-22.6M | $27.9M | ||
| Q2 25 | $-12.6M | $59.6M | ||
| Q1 25 | $-35.2M | $11.4M | ||
| Q4 24 | $-20.1M | $14.3M | ||
| Q3 24 | $-38.7M | $12.4M | ||
| Q2 24 | $-29.3M | $-1.0M | ||
| Q1 24 | $-30.1M | $-8.2M |
毛利率PLRIGL
| Q4 25 | 57.3% | 91.5% | ||
| Q3 25 | 57.6% | 93.2% | ||
| Q2 25 | 55.2% | 95.6% | ||
| Q1 25 | 62.1% | 91.7% | ||
| Q4 24 | 61.2% | 89.9% | ||
| Q3 24 | 52.9% | 85.5% | ||
| Q2 24 | 52.4% | 92.4% | ||
| Q1 24 | 55.2% | 93.1% |
营业利润率PLRIGL
| Q4 25 | -22.6% | 33.2% | ||
| Q3 25 | -24.5% | 40.9% | ||
| Q2 25 | -34.4% | 60.1% | ||
| Q1 25 | -31.5% | 23.9% | ||
| Q4 24 | -36.9% | 28.9% | ||
| Q3 24 | -64.8% | 25.4% | ||
| Q2 24 | -57.2% | 1.2% | ||
| Q1 24 | -57.6% | -23.6% |
净利率PLRIGL
| Q4 25 | -72.8% | 384.0% | ||
| Q3 25 | -30.8% | 40.2% | ||
| Q2 25 | -19.1% | 58.6% | ||
| Q1 25 | -57.1% | 21.5% | ||
| Q4 24 | -32.8% | 24.9% | ||
| Q3 24 | -63.3% | 22.5% | ||
| Q2 24 | -48.5% | -2.8% | ||
| Q1 24 | -51.1% | -27.9% |
每股收益（稀释后）PLRIGL
| Q4 25 | $-0.19 | $14.11 | ||
| Q3 25 | $-0.07 | $1.46 | ||
| Q2 25 | $-0.04 | $3.28 | ||
| Q1 25 | $-0.12 | $0.63 | ||
| Q4 24 | $-0.07 | $0.82 | ||
| Q3 24 | $-0.13 | $0.70 | ||
| Q2 24 | $-0.10 | $-0.06 | ||
| Q1 24 | $-0.10 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $443.3M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $349.6M | $391.5M |
| 总资产 | $1.1B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资PLRIGL
| Q4 25 | $443.3M | $155.0M | ||
| Q3 25 | $181.1M | $137.1M | ||
| Q2 25 | $133.5M | $108.4M | ||
| Q1 25 | $118.0M | $77.1M | ||
| Q4 24 | $139.0M | $77.3M | ||
| Q3 24 | $148.3M | $61.1M | ||
| Q2 24 | $107.4M | $49.1M | ||
| Q1 24 | $83.9M | $49.5M |
总债务PLRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益PLRIGL
| Q4 25 | $349.6M | $391.5M | ||
| Q3 25 | $435.7M | $117.6M | ||
| Q2 25 | $444.8M | $81.9M | ||
| Q1 25 | $441.3M | $18.6M | ||
| Q4 24 | $464.6M | $3.3M | ||
| Q3 24 | $473.2M | $-14.6M | ||
| Q2 24 | $500.3M | $-29.9M | ||
| Q1 24 | $518.0M | $-31.7M |
总资产PLRIGL
| Q4 25 | $1.1B | $513.6M | ||
| Q3 25 | $696.4M | $242.5M | ||
| Q2 25 | $658.4M | $206.7M | ||
| Q1 25 | $633.8M | $176.0M | ||
| Q4 24 | $630.8M | $164.0M | ||
| Q3 24 | $658.4M | $139.4M | ||
| Q2 24 | $674.6M | $128.4M | ||
| Q1 24 | $702.0M | $126.5M |
负债/权益比PLRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $28.6M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $1.9M | — |
| 自由现金流率自由现金流/营收 | 2.3% | — |
| 资本支出强度资本支出/营收 | 32.9% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $40.7M | — |
8季度趋势，按日历期对齐
经营现金流PLRIGL
| Q4 25 | $28.6M | $22.0M | ||
| Q3 25 | $67.8M | $24.0M | ||
| Q2 25 | $17.3M | $30.5M | ||
| Q1 25 | $-6.3M | $-893.0K | ||
| Q4 24 | $4.1M | $14.5M | ||
| Q3 24 | $-7.9M | $21.7M | ||
| Q2 24 | $-4.3M | $302.0K | ||
| Q1 24 | $-6.8M | $-5.0M |
自由现金流PLRIGL
| Q4 25 | $1.9M | — | ||
| Q3 25 | $47.5M | — | ||
| Q2 25 | $9.2M | — | ||
| Q1 25 | $-17.9M | — | ||
| Q4 24 | $-3.6M | — | ||
| Q3 24 | $-23.0M | — | ||
| Q2 24 | $-14.2M | — | ||
| Q1 24 | $-15.7M | — |
自由现金流率PLRIGL
| Q4 25 | 2.3% | — | ||
| Q3 25 | 64.7% | — | ||
| Q2 25 | 13.9% | — | ||
| Q1 25 | -29.1% | — | ||
| Q4 24 | -5.8% | — | ||
| Q3 24 | -37.6% | — | ||
| Q2 24 | -23.6% | — | ||
| Q1 24 | -26.7% | — |
资本支出强度PLRIGL
| Q4 25 | 32.9% | — | ||
| Q3 25 | 27.6% | — | ||
| Q2 25 | 12.3% | — | ||
| Q1 25 | 18.9% | — | ||
| Q4 24 | 12.5% | — | ||
| Q3 24 | 24.8% | — | ||
| Q2 24 | 16.4% | — | ||
| Q1 24 | 15.1% | — |
现金转化率PLRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PL
| Defense And Intelligence | $49.4M | 61% |
| Civil Government | $18.8M | 23% |
| Commercial | $13.1M | 16% |
RIGL
暂无分部数据
